Background/Aims: Leptin, an adipocytokine produced endogenously in the brain, is decreased in Alzheimer's disease(AD) and has also been shown to reduce Aβ levels in vitro and in vivo. Sets of evidence show that leptin reduces Aβ production and tau phosphorylation in neuronal cells and transgenic mice models of AD. Herein, we investigated the signaling pathway activated by leptin, to better understand its mechanism of action. Methods: Western blotting was performed to assess the levels of phosphor-tau and Bax, RT-PCR to check the mRNA level of Bax. Results: Leptin treatment significantly blunted Aβ-evoked tau phosphorylation and Bax levels, effects of which could be reversed by antagonist of Wnt signaling. Conclusion: The data indicate that Leptin may provide a novel therapeutic approach to AD treatment via wnt signaling.
Introduction
The most common neurodegenerative dementia is Alzheimer's disease (AD), which is characterized by two major pathological hallmarks: the deposition and accumulation of β-amyloid (Aβ) peptide in extracellular plaques, the deposition of hyper-phosphorylated tau in intracellular neurofibrillary tangles (NFTs) [1] . Compared to Aβ plaques, NFT with the brain correlates better with neurodegeneration and cognitive decline [2] .
Leptin is a 16-kDa peptide hormone and inflammatory cytokine involved in regulating food intake, metabolism, body fat, energy expenditure and neuroendocrine function [3] . Moreover, a decline of leptin levels is common in AD [4] . Additionally, leptin reduces Aβ levels in vitro and in vivo [5] [6] [7] . Sets of evidence show that leptin reduces Aβ production and tau phosphorylation in neuronal cells and transgenic mice models of AD [8, 9] . Fewlass et al. has found the leptin's ability to modify Aβ levels in vitro and in vivo [10] . Interestingly, leptin suppresses Aβ degradation in astrocytes and increases apoE-dependent Aβ uptake in vitro [10] . Indeed, leptin signaling is involved in ApoE gene expression and would exert this effect on the removal of Aβ aggregates [11] . Therefore, leptin modulates bidirectional Aβ kinesis reducing its extracellular levels [12] .
Moreover, leptin up-regulates Wnt in breast cancer cells [13] . Wnt/ β-catenin signaling pathway is involved not only in the formation of the embryonic dorsoventral axis, but also in a number of other developmental events that depend on establishment of cell polarity or determination of cell fate [14] . Glycogen synthase kinase 3(GSK3), a key component of the β-catenin destruction complex, phosphorylates β-catenin at Ser33, Ser37, and Thr41, leading to its degradation by the proteasome [15, 16] . Of note, GSK-3 is highly expressed in the brain of AD patients [17] , which results in the over-phosphorylation of Tau and the formation of NTF [18] .
We have previously described that Wnt/β-catenin signaling pathway is involved in the neurotoxic effects of Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [19] . Herein, we investigated whether leptin regulated tau phosphorylation via Wnt signaling pathway in Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] -pretreated PC12 cells.
Materials and Methods

Cell culture
Highly differentiated neuron-like PC12 cells(Shanghai Institutes for Biological Sciences, the Chinese Academy of Sciences, Shanghai, China) were cultured in DMEM medium supplemented with 10% FCS and 1% penicillin/streptomycin under standard conditions.
It is reported that addition of purified Aβ and of its active fragment Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] can induce apoptosis in a variety of mammalian cell type in vitro [20] . Therefor, Cells grown on the coverslips were pretreated in 30 μM Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] (Sigma Aldrich,USA) in the presence or absence of leptin(Sigma Aldrich,USA) and/or Wnt antagonist DKK1(Sigma Aldrich,USA) for 24h.
Western blotting
To examine the protein abundance, cells were lysed in RIPA buffer (Beyotime, Shanghai, China) containing 1% phenylmethylsulfonyl fluoride (Beyotime) and 1% protein phosphatase inhibitor (Beyotime) on ice for 30 min. The samples were centrifuged at 14,000 rpm and 4°C for 20 min. Loading buffer (Beyotime, Shanghai, China) was added to the protein lysate, which then were incubated at 95ºC for 5 min.
Total proteins (40-60 µg) were separated by electroporation on 10% SDS-PAGE. For immunoblotting proteins were electro-transferred onto PVDF membranes and blocked with 5% nonfat milk in triethanolaminebuffered saline (TBS) with 0.1% Tween 20 (TBS-T) at room temperature for 1 h. Then, the membrane was incubated with polyclonal rabbit anti-p-tauSer235(1:1000, cell signaling), Bax(1:1000, cell signaling) at 4°C overnight. All antibodies were diluted in TBS-T with 5% BSA. After washing with TBST the blots were incubated with secondary anti rabbit secondary antibody (1:2000, Sigma, United States) for 1 h at room temperature. After washing antibody binding was visualized with enhanced chemiluminescence reagents(Beyotime, Shanghai, China). Membranes were also probed with Actin antibody as loading control. Densitometric analysis was performed using quantity One software (Abbiotec, United States).
Quantification of mRNA expression
Total RNA was extracted from PC12 cells in TriFast (Peqlab, United States) according to the manufacturer's instructions. After DNAse digestion reverse transcription of total RNA was performed using Transcriptor High Fidelity cDNA Synthesis Kit (Roche Diagnostics, United States). Real-time polymerase chain reaction (RT-PCR) of the respective genes were set up in a total volume of 20 µl using 40 ng of cDNA, 500 nM forward and reverse primer and 2x GoTaq® qPCR Master Mix (Promega, United States) according to the manufacturer's protocol. Cycling conditions were as follows: initial denaturation at 95°C for 2 min, followed by 40 cycles of 95°C for 15 sec, 58°C for 15 sec and 68°C for 20 sec. For amplification the following primers were used (5`>3`orientation):
Results
In order to explore whether the effect of leptin on Aβ 25-35 -mediated tau phosphorylation is Wnt-dependent, Aβ 25-35 -pretreated PC12 cells were treated with leptin(125 ng/ml) in the presence or absence of DKK1(100 ng/ml). As illustrated in Fig. 1 , leptin significantly alleviated Leptin-mediated inhibition of Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] phosphorylation of Tau at Ser235.
The BAX gene was the first identified pro-apoptotic member of the Bcl-2 protein family. Western Blot was utilized to quantity the expression of Bax protein in PC12 cells. As shown in Fig. 2 , the expression level of Bax protein in control group was less than that in Aβ 25-35 group, and leptin blocked Aβ 25-35 -induced increase of Bax expression. In addition, DKK1(100 ng/ml) significantly blunted Leptin-regulated inhibition of Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] upon the protein abundance of Bax.
In order to confirm whether Wnt/β-catenin signaling pathway associates with the mRNA levels of Bax, qRT-PCR was utilized. As illustrated in Fig. 3 , leptin(125 ng/ml) alleviated Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] -mediated increase of Bax, the effect of which was affected by DKK1.
GSK3 is a key component of the β-catenin destruction complex. To further understand the role of leptin, Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] -pretreated PC12 cells were treated with leptin in the absence and presence of DKK1, then Western blot was applied. As illustrated in Fig. 4 , treatment with DKK1(100 ng/ml) blunted Leptin-mediated inhibition of GSK3 protein abundance. 
Discussion
This study was conceived to assess the role of leptin signaling in the modulation of AD and explore the related mechanism. Leptin is known to activate Wnt in cancer cells [22] , and we have previously demonstrated that Wnt/β-catenin signaling pathway blunted Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] -mediated inhibition upon Bcl-2/Bax ratio in PC12 cells by affecting GSK3 [19, 23] . Our present findings indicate that Wnt mediates leptin's effect upon tau phosphorylation and apoptosis.
Leptin, the level of which is significantly decreased in AD patients, improves cognitive disorders and referred to as a potential cognitive enhancer [24] . Reports have shown that Leptin reduces Aβ levels both in vitro and in vivo, and inhibits tau phosphorylation in neuronal cultures [7] . Moreover, leptin is known to activate Wnt via Jak2 signaling pathway in cancer cells [22] , but it is still elusive as to how leptin modulates Wnt signaling in neuronal cells. Sets of evidence point to a possible role for Wnt in AD [25] [26] [27] . Precisely, De Ferrari et al. found that Aβ-dependent neurotoxicity induced a loss of function of Wnt signaling components [25] .We showed that leptin abrogated Aβ-induced tau phosphorylation and apoptosis-related protein, an effect of which is Wnt dependent.
GSK3β, a downstream effector of Wnt signaling pathway, is highly expressed in the brain of AD patients [17] and results in the over-phosphorylation of Tau and the formation of NTF [18] . It is known that Aβ promotes GSK3 activation [28] . We found that inhibition of Wnt reversed leptin-reduced GSK-3β expression in PC12 cells. These findings suggest that Leptin, and potentially Wnt activators, may provide a novel therapeutic approach to AD treatment.
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